Omnicell, Inc. OMCL
33.18 USD -1.48 (-4.27%)
Regular-session close
33.18 0.00 0.00%
After hours · Nov 19, 4:07 PM ET
32.97 Day range 34.91
31.75 52-week range 55.00
- YTD
- -26.75%
- 1 year
- -3.91%
News
zacks.com Here's Why Omnicell (OMCL) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com Is This the Right Time to Retain Omnicell Stock in Your Portfolio? OMCL advances its growth strategy through Titan XT, OmniSphere and recurring revenues, while cost discipline boosts profitability.
zacks.com Beat Value Traps: 4 Stocks With Attractive PEG Ratios to Buy Now Discover four stocks with attractive PEG ratios, strong earnings growth prospects and favorable value scores that could help investors avoid value traps.
zacks.com Buy These 3 Stocks with Broker Rating Upgrades for Big Gains Cinemark Holdings, Diamondback Energy and Omnicell stand out with recent broker rating upgrades and strong projected earnings growth for 2026.
zacks.com 4 Undervalued Stocks That Could Benefit from a Wall Street Rally Wall Street's rally puts undervalued stocks in focus. AVT, OMCL, HPE and LCUT stand out for attractive valuations, earnings growth prospects and upside potential.
zacks.com Why Omnicell (OMCL) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
defenseworld.net Contrasting Coloplast A/S (OTCMKTS:CLPBY) & Omnicell (NASDAQ:OMCL) Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and Omnicell (NASDAQ: OMCL - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses…
zacks.com Why Omnicell (OMCL) Might be Well Poised for a Surge Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com OMCL vs. VEEV: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking…
zacks.com Top Robotics Stocks With Strong Potential for Long-Term Growth Robotics is poised for robust long-term growth. Consider OMCL, SNPS, CDNS and MCHP for potential market dominance across sectors.
zacks.com Best Momentum Stocks to Buy for November 5th HTO, CR and OMCL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 5, 2026.
zacks.com Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect? The consensus price target hints at a 40.8% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings…
zacks.com New Strong Buy Stocks for November 5th HTO, SWKS, OMCL, CR and EXPD have been added to the Zacks Rank #1 (Strong Buy) List on November 5, 2026.
zacks.com Best Value Stocks to Buy for November 5th HTO, and OMCL made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 5, 2026.
zacks.com Why Omnicell (OMCL) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.benzinga.com Freedom Capital Markets Maintains Buy on Omnicell, Lowers Price Target to $55 Freedom Capital Markets analyst Gene Mannheimer maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $60 to $55.
seekingalpha.com Omnicell, Inc. (OMCL) Q3 2026 Earnings Call Transcript Omnicell, Inc. ( OMCL ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants David Unger - Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman & CEO…
marketbeat.com Omnicell Q3 Earnings Call Highlights Omnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan…
zacks.com Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 Earnings While the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
benzinga.com Omnicell Q3 2026 Earnings Call Transcript Omnicell (NASDAQ:OMCL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates Omnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.benzinga.com Omnicell Sees Q4 Adj EPS $0.41-$0.49 vs $0.37 Est; Sees Sales $295.000M-$301.000M vs $310.442M Est Omnicell (NASDAQ:OMCL) is looking for Q4 Adj EPS of $0.41-$0.49 vs $0.37 analyst estimate. sees sales of $295.000 million-$301.000 million vs $310.442 million analyst estimate.
benzinga.com Omnicell Raises FY2026 Adj EPS Guidance from $2.15-$2.30 to $2.48-$2.56 vs $2.27 Est; Narrows FY2026 Sales Guidance from $1.225B-$1.245B to $1.225B-$1.231B vs $1.237B Est Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $2.15-$2.30 to $2.48-$2.56 vs $2.27 analyst estimate. Narrows FY2026 sales outlook from $1.225 billion-$1.245 billion to $1.225…
benzinga.com Omnicell Q3 Adj. EPS $0.58 Beats $0.42 Estimate, Sales $307.851M Beat $304.474M Estimate Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.42 by 38.1 percent. This is a 13.73 percent increase over earnings of $0.51 per…
businesswire.com Omnicell Announces Third Quarter 2026 Financial Results FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2026 Financial Results.
